Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rinke J. Borgonjen"'
Autor:
Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof, Elke M.G.J. de Jong, Satish F.K. Lubeek
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world
Externí odkaz:
https://doaj.org/article/b6dd0bf362624e779b7876286616c000
Autor:
Satish F.K. Lubeek, Celia A.J. Michielsens, Rinke J. Borgonjen, Ewald M. Bronkhorst, Peter C.M. Kerkhof, Marie-Jeanne P. Gerritsen
Publikováno v:
Acta Dermato-Venereologica, Vol 97, Iss 7, Pp 825-829 (2017)
Appropriate medical decision-making in patients with keratinocyte skin cancer (KSC) can be challenging, especially in those with a limited life expectancy (LEx). Treatment should be beneficial for the individual patient, the risk of both over- and un
Externí odkaz:
https://doaj.org/article/895ce6c448904c5aaa9d52f475a7a914
Autor:
L.A.A. Gerbens, Astrid M. van Huizen, Cathelijne M. J. M. Bik, F.M. Vermeulen, Rinke J. Borgonjen, Phyllis I. Spuls, Rosanna A. Kuin, Saskia A. T. Karsch
Publikováno v:
Journal of dermatological treatment.
If an authorized drug is prescribed for a use that is not described in the Summary of Product Characteristics, this is defined as 'off-label use.' Methotrexate is often used off-label for dermatological indications. Off-label use is permitted if phys
Publikováno v:
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, 4, pp. e135-e137
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, e135-e137
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, e135-e137
The number of clinical practice guidelines is increasing, but their quality is variable.1 However, healthcare professionals/users should be able to rely on methodologically sound guidelines that are helpful and applicable in practice. To objectively
Autor:
Peter C.M. van de Kerkhof, Ewald M. Bronkhorst, Satish F K Lubeek, Rinke J Borgonjen, Celia A J Michielsens, Marie-Jeanne P. Gerritsen
Publikováno v:
Acta Dermato-Venereologica, 97, 7, pp. 825-829
Acta Dermato-Venereologica, 97, 825-829
Acta Dermato-Venereologica, Vol 97, Iss 7, Pp 825-829 (2017)
Acta Dermato-Venereologica, 97, 825-829
Acta Dermato-Venereologica, Vol 97, Iss 7, Pp 825-829 (2017)
Contains fulltext : 177147.pdf (Publisher’s version ) (Open Access) Appropriate medical decision-making in patients with keratinocyte skin cancer (KSC) can be challenging, especially in those with a limited life expectancy (LEx). Treatment should b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b5a7e953ec368e09f837ae8b28a1b2
https://hdl.handle.net/2066/177147
https://hdl.handle.net/2066/177147
Autor:
Jan G. van der Schroeff, Phyllis I. Spuls, Cathelijne M. J. M. Bik, M. E. Schram, Jannes J. E. van Everdingen, Rinke J. Borgonjen
Publikováno v:
Archives of dermatology. 147(4):474-488
Objective: To summarize evidence regarding the effectiveness, efficacy, and safety of off-label azathioprine use in dermatology. Data Sources: We searched the MEDLINE (1950-2009), EMBASE (1980-2009), and CENTRAL (1996-2009) databases on October 9, 20
Autor:
Hok Bing Thio, Marcel C. Pasch, H van Deutekom, C.L.M. van Hees, J de Bes, J.J.E. van Everdingen, L.A. Torcque, M. de Groot, O.D. van Cranenburgh, P.A. Poblete-Gutierrez, L.L.A. Lecluse, E.M.G.J. de Jong, Tamar Nijsten, J. de Korte, Errol P. Prens, Marieke M B Seyger, H Hulshuizen, P.C.M. van de Kerkhof, Rinke J. Borgonjen, M te Booij, A.C. de Vries, W.J.A. de Korte, Marcel Koek, Jeffrey Zweegers, Ph.I. Spuls
Publikováno v:
Dermatology Online Journal, 20, 3, pp. 1
Dermatology Online Journal, 20, 1
Zweegers, J; de Jong, E.M.G.J.; Nijsten, T.E.C.; de Bes, J; te Booij, M; Borgonjen, R.J.; et al.(2014). Summary of the Dutch S3-Guidelines on the treatment of psoriasis 2011. Dermatology Online Journal, 20(3). Retrieved from: http://www.escholarship.org/uc/item/93n3j5s9
Scopus-Elsevier
Dermatology Online Journal, 20, 1
Zweegers, J; de Jong, E.M.G.J.; Nijsten, T.E.C.; de Bes, J; te Booij, M; Borgonjen, R.J.; et al.(2014). Summary of the Dutch S3-Guidelines on the treatment of psoriasis 2011. Dermatology Online Journal, 20(3). Retrieved from: http://www.escholarship.org/uc/item/93n3j5s9
Scopus-Elsevier
Contains fulltext : 136885.pdf (Publisher’s version ) (Open Access) This document provides a summary of the Dutch S3-guidelines on the treatment of psoriasis. These guidelines were finalized in December 2011 and contain unique chapters on the treat
Autor:
Cathelijne M. J. M. Bik, Peter C.M. van de Kerkhof, Phyllis I. Spuls, Mariska K Tuut, Rinke J. Borgonjen, Jannes J. E. van Everdingen
Publikováno v:
BMJ quality & safety, 20(10), 832-841. BMJ Publishing Group
BMJ Quality and Safety, 20, 832-41
BMJ Quality and Safety, 20, 10, pp. 832-41
BMJ Quality and Safety, 20, 832-41
BMJ Quality and Safety, 20, 10, pp. 832-41
Item does not contain fulltext OBJECTIVE: To compare three methods of guideline development, to see whether using alternative evidence-based methods resulted in variation of recommendations for treating actinic keratosis. METHODS: Method 1 followed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c08901c73c4b50fc74b74eb0f13cca3
https://dare.uva.nl/personal/pure/en/publications/prospective-comparison-of-three-guideline-development-methods-for-treatment-of-actinic-keratosis(a989f18e-e889-4a35-b3d6-0b80a59909f3).html
https://dare.uva.nl/personal/pure/en/publications/prospective-comparison-of-three-guideline-development-methods-for-treatment-of-actinic-keratosis(a989f18e-e889-4a35-b3d6-0b80a59909f3).html